Amir Debourou is an Associate Director responsible for identifying and developing investment opportunities across digital health and health information technology. Amir brings a wide range of investing and operational experiences. Prior to joining the GHI Fund, Amir led the Corporate Development function of Merck’s Animal Health business. Previously Amir was with PineBridge Investments and Khaya Capital focusing primarily on emerging markets private equity investments. In addition, Amir has experience as a strategy consultant with Capgemini. Amir holds an MBA from University of Chicago's Booth School of Business, a MSc Management information Systems from ESIEE Paris and a BSc Chemistry from the University of Poitiers.